1070 J . Org. Chem., Vol. 67, No. 4, 2002
Faure et al.
1.93-2.25 (m, 3H), 3.13 (dd, 1H, J ) 11.0, 6.6 Hz), 4.29 (ddd,
1H, J AB ) 11.4 Hz, J ) 8.8, 2.9 Hz), 4.48 (ddd, 1H, J AB ) 11.4
Hz, J ) 6.1, 3.4 Hz); 13C NMR (62 MHz, CDCl3) δ 20.1, 27.6,
28.9, 31.4, 35.3, 38.8, 45.0, 46.6, 67.3, 175.3, 211.1; IR (neat)
ν 2936, 2872, 1718, 1265, 1293, 1153, 1064 cm-1. Anal. Calcd
for C11H14O3: C, 68.03; H, 7.27. Found: C, 68.11; H, 7.58.
Keta l (29). Prepared using the same protocol than 26, from
(2R,3R)-2,3-butanediol and 28a /28b: 1H NMR (250 MHz,
CDCl3) major adduct: δ 1.20 (d, 3H, J ) 5.6 Hz), 1.21 (d, 3H,
J ) 5.4 Hz), 1.52 (ddd, 1H, J AB ) 14.2 Hz, J ) 11.4, 4.2 Hz),
1.70-1.90 (m, 5H), 1.95 (m, 1H), 2.03 (m, 1H), 2.16 (d, 1H,
J AB ) 14.2 Hz), 2.30-2.40 (m, 2H), 2.64 (dd, 1H, J ) 9.2, 8.6
Hz), 3.53 (dq, 1H, J ) 8.2, 6.0 Hz), 3.61 (dq, 1H, J ) 8.2, 6.0
Hz), 4.29 (ddd, 1H, J AB ) 11.0 Hz, J ) 7.1, 3.4 Hz), 4.54 (ddd,
1H, J AB ) 11.0 Hz, J ) 7.9, 2.9 Hz); 1H NMR (250 MHz, CDCl3)
minor adduct (characteristic signal): δ 2.57 (dd, 1H, J ) 9.2,
8.6 Hz); 13C NMR (62 MHz, CDCl3) major adduct: δ 16.8, 16.9,
19.8, 25.2, 28.3, 30.8, 32.7, 36.0, 42.0, 43.7, 67.3, 78.0, 78.1,
107.3, 174.9; IR (neat) ν 2922, 2860, 1718, 1454, 1265, 1178,
1089 cm-1; MS (EI, 70 eV) m/z 266 (M•+, 14), 149 (16), 141
(25), 127 (100).
(dd, 1H, J ) 12.5, 8.1 Hz), 2.17 (dd, 1H, J ) 12.5, 10.5 Hz),
3.07 (dd, 1H, J ) 10.5, 8.1 Hz), 4.26 (ddd, 1H, J AB ) 11.6 Hz,
J ) 8.1, 3.1 Hz), 4.42 (ddd, 1H, J AB ) 11.6 Hz, J ) 6.8, 3.2
Hz); 13C NMR (CDCl3) δ 21.0, 23.1, 25.7, 35.3, 37.4, 38.3, 38.6,
42.8, 49.2, 66.2, 175.4, 211.5; IR (neat) ν 2935, 2875, 1730,
1695, 1455, 1405, 1265, 1190, 1065 cm-1; MS (70 eV) m/z 208
(M•+, 14), 190, 149, 139, 135, 126, 123, 109; [R]21 ) -89 (c
D
0.9, CHCl3). Anal. Calcd for C12H16O3: C, 69.19; H, 7.75.
Found: C, 69.03; H, 7.91.
(1R,6S,8R)-7,7-Dim et h yl-3-oxa t r icyclo[6.4.01,6.01,8]d o-
d eca n e-2,9-d ion e (35): solid, 78%; 1H NMR (500 MHz,
CDCl3) δ 1.05 (s, 3H), 1.14 (s, 3H), 1.86-2.06 (m, 5H), 2.13
(m, 1H), 2.29 (ddd, 1H, J AB ) 18.0 Hz, J ) 9.5, 5.3 Hz), 2.41
(ddd, 1H, J AB ) 18.0 Hz, J ) 5.6, 5.1 Hz), 2.53 (t, 1H, J ) 9.5
Hz), 2.88 (s, 1H), 4.19 (ddd, 1H, J AB ) 11.0 Hz, J ) 2.0, 12.1
Hz), 4.46 (ddd, 1H, J AB ) 11.0 Hz, J ) 3.9, 2.6 Hz); 13C NMR
(CDCl3) δ 18.9, 23.8, 26.7, 32.1, 38.2, 40.0, 41.0, 45.3, 55.9,
67.5, 176.9, 209.4; IR (neat) ν 2960, 2895, 1730, 1680, 1480,
1390, 1205, 1055, 980 cm-1; MS (70 eV) m/z 222 (M•+, 25), 194,
179, 167, 149, 137, 124, 118, 111, 107; [R]21 ) -63 (c 0.9,
D
CHCl3). Anal. Calcd for C13H18O3: C, 70.24; H, 8.16. Found:
C, 70.36; H, 8.21.
(1R,4S,9S,11R)-4-P h en yl-3,6-d ioxa tr icyclo[9.4.01,11.01,9]-
pen tadecan e-2,5,12-tr ion e (30): solid, 62%; 1H NMR (CDCl3)
δ 1.49 (d, 1 H, J ) 15.2 Hz), 1.80-2.20 (m, 4 H), 2.20-2.65
(m, 5 H), 2.67-2.80 (m, 1 H), 3.60 (dd, 1 H, J ) 11.2, 8.2 Hz),
3.74 (ddd, 1 H, J AB ) 11.2 Hz, J ) 12.2, 3.2 Hz), 4.89 (dd, 1 H,
J AB ) 11.2 Hz, J ) 5.0 Hz), 6.07 (s, 1 H), 7.39-7.41 (m, 3 H,),
7.50-7.55 (m, 2 H); 13C NMR (CDCl3) δ 21.0, 28.2, 29.9, 31.6,
38.2, 42.0, 43.0, 52.9, 65.4, 79.9, 126.9, 128.8, 129.4, 132.1,
169.3, 175.7, 211.4; IR (neat) ν 2947, 2860, 1743, 1705, 1454,
1228, 1103, 1028, 702 cm-1; MS (70 eV) m/z 328 (M+•, 17), 222,
(1S,4S,9S,11R)-4-Meth yl-3,6-d ioxa tr icyclo[9.3.01,11.01,9]-
tetr adecan e-2,5,12-tr ion e (36a): solid, 36%; 1H NMR (CDCl3)
δ 1.67 (d, 3H, J ) 6.9 Hz), 1.70-1.90 (m, 1H), 1.90-2.55 (m,
6H), 2.65-2.90 (m, 2H), 3.14 (dd, 1H, J ) 11.2, 4.4 Hz), 4.19
(ddd, 1H, J AB ) 11.4 Hz, J ) 7.2, 4.2 Hz), 4.53 (ddd, 1H, J AB
) 11.4 Hz, J ) 6.5, 4.6 Hz), 5.00 (q, 1H, J ) 6.9 Hz); 13C NMR
(CDCl3) δ 16.1, 25.8, 29.9, 33.1, 37.3, 42.9, 44.1, 55.1, 63.8,
74.9, 171.1, 176.5, 218.6; IR (neat) ν ) 2922, 2850, 1743, 1440,
1280, 1165, 1055 cm-1; MS (70 eV) m/z 252 (M•+, 22), 224, 109;
195, 178, 150, 123, 118, 105; [R]21 ) -141 (c ) 0.97, CHCl3).
[R]21 ) +197 (c ) 0.3, CHCl3).
D
D
Anal. Calcd for C19H20O5: C, 69.49; H, 6.13. Found: C, 69.70;
H, 6.07.
(1R,4S,9R,11S)-4-Meth yl-3,6-d ioxa tr icyclo[9.3.01,11.01,9]-
tetr adecan e-2,5,12-tr ion e (36b): solid, 28%; 1H NMR (CDCl3)
δ 1.67 (d, 3H, J ) 6.9 Hz), 1.70-1.90 (m, 1H), 1.90-2.55 (m,
6H), 2.65-2.90 (m, 2H), 3.14 (dd, 1H, J ) 12.2, 4.4 Hz), 4.19
(ddd, 1H, J AB ) 11.4 Hz, J ) 7.2, 4.2 Hz), 4.53 (ddd, 1H, J AB
) 11.4 Hz, J ) 6.5, 4.6 Hz), 5.00 (q, 1H, J ) 6.9 Hz); 13C NMR
(CDCl3): δ 15.5, 27.3, 29.1, 32.4, 37.2, 43.5, 54.9, 65.1, 74.6,
171.8, 175.7, 218.1.
(1R,4S,9S,11R)-4-Ben zyl-3,6-d ioxa tr icyclo[9.4.01,11.01,9]-
pen tadecan e-2,5,12-tr ion e (31): solid, 50%; 1H NMR (CDCl3)
δ 1.50-2.55 (m, 11 H), 3.05 (d, 2 H, J ) 6.7 Hz), 3.41 (dd, 1 H,
J ) 11.2, 7.8 Hz), 3.64 (td, 1 H, J AB ) 11.4 Hz, J ) 11.4, 3.0
Hz), 4.72 (dd, 1 H, J AB ) 11.4 Hz, J ) 4.0 Hz), 5.22 (t, 1 H, J
) 6.7 Hz), 7.10-7.30 (m, 5 H); 13C NMR (CDCl3) δ 20.8, 28.0,
28.8, 31.5, 36.2, 38.2, 42.1, 42.7, 52.8, 65.3, 78.9, 127.1, 128.5,
129.2, 135.5, 170.5, 176.1, 211.9; MS (70 eV) m/z 342 (M•+, 14),
148, 131. Anal. Calcd for C20H22O5: C, 70.15; H, 6.48. Found:
C, 69.88; H, 6.82.
(1S,4R,9S,11S)-4-Meth yl-3,7-d ioxa tr icyclo[9.4. 01,11.01,9]-
tetr adecan e-2,6,12-tr ion e (37a): solid, 58%; 1H NMR (CDCl3)
δ 1.39 (d, 3 H, J ) 6.1 Hz), 1.90-2.50 (m, 5 H), 2.51 (ddd, 1 H,
J ) 9, 3, 1.9 Hz), 3.65-2.83 (m, 3 H), 3.07 (dd, 1 H, J ) 9.3,
5 Hz), 3.87 (d, 1 H, J AB ) 12.2 Hz), 4.61 (dd, 1 H, J AB ) 12.2
Hz, J ) 2 Hz), 5.50 (m, 1 H); 13C NMR (CDCl3) δ 20.1, 23.1,
30.2, 36.7, 40.7, 42.9, 44.1, 52.7, 64.9, 67.4, 170.6, 173.9, 218.6;
(1 R ,4 S ,9 S ,1 1 R )-4 ,9 -D i m e t h y l -3 ,6 -d i o x a t r i c y c l o -
[9.4.0.1,11.01,9]tetr a d eca n e-2,5,12-tr ion e (32): solid, 65%; 1H
NMR (CDCl3) δ 1.29 (s, 3H), 1.51 (s, 3H), 1.60-1.80 (m, 1H),
1.96 (td, 1H, J ) 13.0, 3.3 Hz), 1.98 (t, 2H, J ) 10.8 Hz), 2.05-
2.15 (m, 1H), 2.10 (t, 1H, J ) 11.0 Hz), 2.30-2.42 (m, 2H),
2.50-2.60 (m, 2H), 3.57 (t, 1H, J ) 10.4 Hz), 3.93 (ddd, 1H,
J AB ) 12.0 Hz, J ) 12.2, 3.9 Hz), 4.74 (dd, 1H, J AB ) 12.0 Hz,
J ) 6.0 Hz), 5.14 (q, 1H, J ) 7.0 Hz); 13C NMR (CDCl3) δ 15.3,
19.7, 21.4, 24.4, 36.6, 37.3, 38.2, 69.6, 112.5, 133.6, 141.1, 148.0,
165.8, 170.1, 199.9; IR (neat) ν 2980, 2870, 1755, 1720, 1465,
IR (neat) ν ) 2961, 2922, 1743, 1454, 1304, 1190, 1039 cm-1
MS (70 eV) m/z 252 (M•+, 27), 166, 148, 138, 127, 120, 109.
;
(1R,4R,9R,11R)-4-Meth yl-3,7-d ioxa tr icyclo[9.4 01,11.01,9]-
tetr adecan e-2,6,12-tr ion e (37b): solid, 31%; 1H NMR (CDCl3)
δ 1.40 (d, 3 H, J ) 6.5 Hz), 2.05 (ddd, 1 H, J ) 12.6, 8.5, 4.6
Hz), 2.15-2.44 (m, 4 H), 2.51 (ddd, 1 H, J ) 9.1, 4.6, 1.9 Hz),
2.60-2.80 (m, 2 H), 2.94 (m, 1 H), 3.14 (dd, 1 H, J ) 11, 4.6
Hz), 4.26 (dd, 1 H, J AB ) 11.8 Hz, J ) 8.8 Hz), 4.31 (dd, 1 H,
J AB ) 11.8 Hz, J ) 6.8 Hz), 5.42 (ddq, 1 H, J ) 8.0, 4.6, 6.5
Hz); 13C NMR (CDCl3) δ 19.9, 23.4, 29.0, 37.5, 39.9, 42.9, 43.1,
1380, 1240, 1140, 1105, 1065 cm-1; MS (70 eV) m/z 280 (M•+
,
17), 213, 209, 163, 135, 123, 107; [R]21D ) -156 (c 0.9, CHCl3).
Anal. Calcd for C15H20O5: C, 69.27; H, 7.19. Found: C, 64.26;
H, 7.31.
52.8, 67.1, 67.5, 171.2, 173.2, 217.9; [R]21 -224 (c ) 0.6,
D
(1R,4S,9R,11R)-4,10,10-Tr im et h yl-3,6-d ioxa t r icyclo-
[9.4.01,9.01,11]p en ta d eca n e-2.5 12-tr ion e (33): oil, 81%; 1H
NMR (CDCl3) δ 1.10 (s, 3H), 1.15 (s, 3H), 1.38 (dd, 1H, J )
15.4, 1.2 Hz), 1.51 (d, 3H, J ) 7.0 Hz), 1.71 (m, 1H), 1.80-
2.20 (m, 3H), 2.25-2.40 (m, 3H), 2.72 (ddd, 1H, J ) 14.2, 7.4,
2.8 Hz), 3.16 (s, 1H), 3.69 (ddd, 1H, J AB ) 11.0 Hz, J ) 13.0,
2.5 Hz), 4.89 (ddd, 1H, J AB ) 11.0 Hz, J ) 4.6, 1.0 Hz), 5.17
(q, 1H, J ) 7.0 Hz); 13C NMR (CDCl3) δ 15.6, 20.3, 25.6, 26.7,
27.3, 30.2, 38.6, 40.1, 49.3, 53.1, 53.3, 65.7, 74.7, 172.0, 177.5,
210.7; IR (neat) ν 2960, 2895, 1755, 1695, 1455, 1240, 1055
cm-1; MS (70 eV) m/z 294 (M•+, 28), 222, 213, 176, 149, 135,
CHCl3).
Ack n ow led gm en t. S.F. and S.P.L.B. warmly thank
M.E.N.R.T. and Re´gion Champagne-Ardenne, respec-
tively, for Ph.D. grants. Professor Alix and Mrs. Charton
(Inserm U. 314, Reims) are acknowledged for their help
in recording the CD spectra. O.P. acknowledges C.N.R.S.
for substantial support (AIP 1999-2001).
Su p p or tin g In for m a tion Ava ila ble: ORTEP structure
1
and tables of X-ray crystallography data of compound 21. H
123, 111, 107; [R]21 ) -232 (c 0.9, CHCl3). Anal. Calcd for
and 13C spectra of 3b,c, 7b, 16, 18, 22-24, 27, 36, and 37.
This material is available free of charge via the Internet at
htpp://pubs.acs.org.
D
C
16H22O5: C, 65.29; H, 7.53. Found: C, 65.53; H, 7.81.
(1R,6S,8R)-6-Meth yl-3-oxatr icyclo[6.4.01,6.01,8]dodecan e-
1
2,9-d ion e (34): solid, 69%; H NMR (CDCl3) δ 1.13 (s, 3H),
1.74 (ddd, 1H, J ) 14.5, 6.8, 3.1 Hz), 1.80-2.40 (m, 7H), 2.07
J O001631E